T8	Subject 20 76	A 34-year-old woman with chronic hepatitis C, genotype 3
T9	Treatment 88 144	pegylated interferon alpha-2a and ribavirin for 6 months
T10	Effect 156 186	progressive malaise and anemia
T11	Age 22 33	34-year-old
T12	Gender 34 39	woman
T13	Sub-Disorder 66 76	genotype 3
T14	Duration 136 144	6 months
T16	Drug 88 117	pegylated interferon alpha-2a
T17	Drug 122 131	ribavirin
T7	Adverse_event 146 155	developed
T15	Combination 118 121	and
E1	Adverse_event:T7 
E2	Combination:T15 arg:T17 arg2:T16
T1	Time_elapsed 187 195	6 months
T2	Treat-Disorder 45 64	chronic hepatitis C
